Arginine Vasopressin in Advanced Vasodilatory Shock
Top Cited Papers
- 13 May 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (18) , 2313-2319
- https://doi.org/10.1161/01.cir.0000066692.71008.bb
Abstract
Background— Vasodilatory shock is a potentially lethal complication of severe disease in critically ill patients. Currently, catecholamines are the most widely used vasopressor agents to support bl...Keywords
This publication has 25 references indexed in Scilit:
- Depletion of neurohypophyseal content of vasopressin in septic shock*Critical Care Medicine, 2002
- The Effects of Vasopressin on Systemic Hemodynamics in Catecholamine-Resistant Septic and Postcardiotomy Shock: A Retrospective AnalysisAnesthesia & Analgesia, 2001
- Treatment of Intraoperative Refractory Hypotension with Terlipressin in Patients Chronically Treated with an Antagonist of the Renin-Angiotensin SystemAnesthesia & Analgesia, 1999
- The Effects of Vasopressin on Endotoxin-Induced Attenuation of Contractile Responses in Human Gastroepiploic Arteries In VitroAnesthesia & Analgesia, 1999
- On the Inotropic Actions of Arginine Vasopressin in Ventricular Muscle of the Guinea Pig Heart.The Japanese Journal of Pharmacology, 1999
- Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agentThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Vasopressin for the Treatment of Refractory Hypotension After Cardiopulmonary BypassAnesthesia & Analgesia, 1998
- Arginine vasopressin inhibits interleukin-1β-stimulated nitric oxide and cyclic guanosine monophosphate production via the V1 receptor in cultured rat vascular smooth muscle cellsJournal Of Hypertension, 1997
- Comparison of Peptide and Nonpeptide Receptor-Mediated Responses in Rat Tail ArteryJournal of Cardiovascular Pharmacology, 1992
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992